Scholars Central

Short communicationPublished 24 Jan 2021

21-Hydroxylase Deficiency

Authors: Clemens Remer, Thomas Kamrath

Reports in Endocrine Disorders: Open Access

Volume 5 · Issue 1 · Pages 3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

21-hydroxylase deficiency is one among a group of problems known as congenital adrenal hyperplasias that impair hormone production and disrupt sexual improvement. 21-hydroxylase deficiency is liable for about ninety five percent of all instances of congenital adrenal hyperplasia. 17-Hydroxyprogesterone (17-OHP) may be converted to dihydrotestosterone (DHT) through an opportunity “backdoor” route that bypasses the traditional intermediates androstenedione and testosterone. on this backdoor pathway, 17-OHP is transformed to 5α-pregnane-threeα,17α-diol-20-one (pdiol), that's an wonderful substrate for the 17,20 lyase activity of CYP17A1 to provide androsterone. Objective and Hypotheses: The goal of this observes become to attain proof for the presence of the backdoor pathway in sufferers with 21-hydroxylase deficiency (21-OHD).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Reports in Endocrine Disorders: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalReports in Endocrine Disorders: Open Access
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Clemens Remer”
  • BylineArticles whose byline prints “Thomas Kamrath”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels